article thumbnail

ValueClick Sells Investopedia, PriceRunner To IAC

socalTECH

ValueClick said in November that it was looking to divest that segment of its business, which is based in Monrovia, California. ValueClick said the business unit will continue to be led by Steve Neufer and be based in Monrovia, according to ValueClick. valueclick investopedia pricerunner merger acquisition' READ MORE>>.

article thumbnail

Green Dot Buys GE Capital's Walmart Cards

socalTECH

Monrovia, California-based prepaid card provider Green Dot has acquired the reloadable prepaid card business of GE Capital , which are marketed under the Walmart brand, the firm said today. Financial terms of the acquisition were not announced. card prepaid financial acquisition merger gecapital walmart gdot green greendot'

Capital 191
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Xencor Files For IPO

socalTECH

Monrovia, California-based biopharmaceuticals developer Xencor has filed for an IPO, saying in a filing this morning that it looking to raise up to $69.0M exit acquisition merger biopharmaceuticals biopharma xencor' in its initial public offering. Xencor said it is has applied to trade as XNCR on the NASDAQ Stock Market. READ MORE>>.

Monrovia 185
article thumbnail

Xencor Sets IPO Pricing

socalTECH

Monrovia, California-based Xencor has set the initial offering price for its IPO, saying in a filing Thursday morning that it will offer up 10,700,000 shares of its common stock at $7.00 exit acquisition merger biopharmaceuticals biopharma xencor' The company plans to trade on the NASDAQ Global Market as XNCR. and $16.00 and $16.00

Pricing 157
article thumbnail

Xencor Prices IPO

socalTECH

Monrovia-based biopharmaceuticals developer Xencor said this morning that it has priced its IPO, at $5.50 xencor biopharma biopharmaceuticals merger acquisition exit lifescience' READ MORE>>. xencor biopharma biopharmaceuticals merger acquisition exit lifescience' Xencor sold 12,730,000 shares of its common stock in the IPO.

Pricing 138
article thumbnail

Xencor Delays IPO

socalTECH

Monrovia-based Xencor , the developer of biopharmaceutical technology headed by Bassill Dahiyat, delayed its IPO Friday, citing poor market conditions for the offering. xencor biopharma biopharmaceuticals merger acquisition exit' The company had hoped to IPO on the NASDAQ Global Market. READ MORE>>.

Monrovia 147
article thumbnail

Xencor Sets IPO Pricing Range

socalTECH

Monrovia, California-based Xencor , the biopharmaceuticals technology developer headed by Bassil Dahiyat, has set its IPO pricing range, saying today in a regulatory filing that it is expecting to price its IPO at between $14.00 xencor biopharma biopharmaceuticals merger acquisition exit' and $16.00 Stafford, III. READ MORE>>.

Pricing 138